A Clinical Trial Coordinator plays a central role in the planning and execution of clinical research studies by ensuring that each trial runs smoothly, ethically, and in compliance with regulatory requirements. Their responsibilities include coordinating trial logistics, managing participant schedules, maintaining accurate study documentation, and supporting data collection processes. They act as a point of contact between sponsors, investigators, regulatory bodies, and clinical site staff to ensure consistent communication and timely progress throughout the trial.
In addition to administrative and regulatory duties, Clinical Trial Coordinators are actively involved in participant care, from screening and enrollment to follow-up. They are responsible for ensuring that informed consent is obtained and that study participants are treated according to the trial protocol. They help prepare for site audits and inspections, assist with adverse event reporting, and support data integrity efforts by ensuring timely and accurate data entry. Their in-depth understanding of clinical research guidelines, such as Good Clinical Practice (GCP), allows them to maintain compliance and high ethical standards throughout the trial. They must also manage multiple priorities under tight deadlines and adapt quickly to evolving study needs. Their contribution ensures trials not only meet scientific objectives but also protect participant safety and trust. By balancing clinical, regulatory, and operational tasks, they ensure that each study contributes valid and valuable results to medical research.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico